Tonya Marmon

2.1k total citations
40 papers, 802 citations indexed

About

Tonya Marmon is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Tonya Marmon has authored 40 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 10 papers in Hepatology and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Tonya Marmon's work include Liver Disease Diagnosis and Treatment (15 papers), Liver Diseases and Immunity (10 papers) and Pituitary Gland Disorders and Treatments (4 papers). Tonya Marmon is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Liver Diseases and Immunity (10 papers) and Pituitary Gland Disorders and Treatments (4 papers). Tonya Marmon collaborates with scholars based in United States, United Kingdom and Italy. Tonya Marmon's co-authors include Jürgen Unützer, Roland Sturm, Jess P. Shatkin, Ruth Klap, Kenneth B. Wells, Jürgen Unützer, Alexander S. Young, Wayne Katon, Donald L. Patrick and Gregory E. Simon and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Tonya Marmon

37 papers receiving 765 citations

Peers

Tonya Marmon
Morten Charles Denmark
Zhongrui Yan China
R Zanettini Italy
Francesca Cherubino Italy
Ronghuan Jiang China
Jakob Friis Schmidt Denmark
Brendan Kelley United States
Dawn Farrell Ireland
Jane Vickery United Kingdom
Alireza Ghajar Iran
Morten Charles Denmark
Tonya Marmon
Citations per year, relative to Tonya Marmon Tonya Marmon (= 1×) peers Morten Charles

Countries citing papers authored by Tonya Marmon

Since Specialization
Citations

This map shows the geographic impact of Tonya Marmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tonya Marmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tonya Marmon more than expected).

Fields of papers citing papers by Tonya Marmon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tonya Marmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tonya Marmon. The network helps show where Tonya Marmon may publish in the future.

Co-authorship network of co-authors of Tonya Marmon

This figure shows the co-authorship network connecting the top 25 collaborators of Tonya Marmon. A scholar is included among the top collaborators of Tonya Marmon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tonya Marmon. Tonya Marmon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jabbour, Elias, Timothy P. Hughes, Richard Van Etten, et al.. (2025). CARDINAL: A Phase 1 study of TERN-701, a novel investigational allosteric BCR::ABL1 inhibitor for patients with previously treated CML. Blood. 146(Supplement 1). 901–901.
2.
3.
Noureddin, Mazen, Naim Alkhouri, Eric Lawitz, et al.. (2025). TERN-501 monotherapy and combination therapy with TERN-101 in metabolic dysfunction-associated steatohepatitis: the randomized phase 2a DUET trial. Nature Medicine. 31(7). 2297–2305. 2 indexed citations
4.
Sitbon, Olivier, Andris Skride, Jeremy Feldman, et al.. (2024). Safety and efficacy of rodatristat ethyl for the treatment of pulmonary arterial hypertension (ELEVATE-2): a dose-ranging, randomised, multicentre, phase 2b trial. The Lancet Respiratory Medicine. 12(11). 865–876. 5 indexed citations
5.
Ullman, Julie C., Ryan A. Dick, Todd Minga, et al.. (2024). First‐in‐Human Evaluation of Safety, Pharmacokinetics and Muscle Glycogen Lowering of a Novel Glycogen Synthase 1 Inhibitor for the Treatment of Pompe Disease. Clinical Pharmacology & Therapeutics. 116(6). 1580–1592. 1 indexed citations
6.
Martin, Susan, et al.. (2023). Development and evaluation of the Acromegaly Symptom Diary. Journal of Patient-Reported Outcomes. 7(1). 15–15. 7 indexed citations
7.
Gadelha, Mônica R., Murray B. Gordon, Mirjana Doknić, et al.. (2022). ACROBAT Edge: Safety and Efficacy of Switching Injected SRLs to Oral Paltusotine in Patients With Acromegaly. The Journal of Clinical Endocrinology & Metabolism. 108(5). e148–e159. 19 indexed citations
8.
9.
10.
Jankovic, Joseph, Ira Goodman, Beth Safirstein, et al.. (2018). Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease. JAMA Neurology. 75(10). 1206–1206. 224 indexed citations
11.
Carbone, Marco, Maren H. Harms, Willem J. Lammers, et al.. (2018). Clinical application of the GLOBE and United Kingdom‐primary biliary cholangitis risk scores in a trial cohort of patients with primary biliary cholangitis. Hepatology Communications. 2(6). 683–692. 19 indexed citations
12.
Hirschfield, Gideon M., Annarosa Floreani, Richard Pencek, et al.. (2017). PTU-097 Long-term effect of obeticholic acid on transient elastography and ast to platelet ratio index in patients with pbc. Gut. 66. A98.3–A99. 1 indexed citations
13.
Kremer, Andreas E., Ulrich Beuers, Tonya Marmon, et al.. (2016). Mitigation of Pruritus during Obeticholic Acid Treatment in Patients with Primary Biliary Cirrhosis: Strategies and Successes. Journal of Hepatology. 64(2). S636–S637. 2 indexed citations
14.
Karpen, Saul J., Lise Eliot, Michelle M. Merrigan, et al.. (2016). A Multicenter, Randomized, Open Label, Single- and Multiple-Dose, Dose Finding Study and Open-Label Extension to Assess the Effects of Obeticholic Acid in Pediatric Patients with Biliary Atresia. Journal of Hepatology. 64(2). S294–S294. 2 indexed citations
15.
Parés, Albert, Richard Pencek, Yonne Peters, et al.. (2015). P1155 : FXR Agonism with obeticholic acid may attenuate bone mineral density decrease in subjects with primary biliary cirrhosis. Journal of Hepatology. 62. S786–S786. 3 indexed citations
16.
Kowdley, K.V., Gideon M. Hirschfield, Robert Chapman, et al.. (2014). P374 LONG-TERM TREATMENT OF PRIMARY BILIARY CIRRHOSIS WITH THE FXR AGONIST OBETICHOLIC ACID SHOWS DURABLE EFFICACY. Journal of Hepatology. 60(1). S192–S193. 3 indexed citations
17.
Webster, Lynn R., et al.. (2012). Randomized, Double-Blind, Placebo-Controlled Study of the Abuse Potential of Different Formulations of Oral Oxycodone. Pain Medicine. 13(6). 790–801. 42 indexed citations
18.
Unützer, Jürgen, Bruce A. Ferrell, Elizabeth Lin, & Tonya Marmon. (2004). Pharmacotherapy of Pain in Depressed Older Adults. Journal of the American Geriatrics Society. 52(11). 1916–1922. 22 indexed citations
19.
Unützer, Jürgen, Donald L. Patrick, Tonya Marmon, Gregory E. Simon, & Wayne Katon. (2002). Depressive Symptoms and Mortality in a Prospective Study of 2,558 Older Adults. American Journal of Geriatric Psychiatry. 10(5). 521–530. 89 indexed citations
20.
Unützer, Jürgen, Ruth Klap, Roland Sturm, et al.. (2000). Mental Disorders and the Use of Alternative Medicine: Results From a National Survey. American Journal of Psychiatry. 157(11). 1851–1857. 204 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Morten Charles Breakdown of academic impact, for papers by Zhongrui Yan Breakdown of academic impact, for papers by R Zanettini Breakdown of academic impact, for papers by Francesca Cherubino Breakdown of academic impact, for papers by Ronghuan Jiang Breakdown of academic impact, for papers by Jakob Friis Schmidt Breakdown of academic impact, for papers by Brendan Kelley Breakdown of academic impact, for papers by Dawn Farrell Breakdown of academic impact, for papers by Jane Vickery Breakdown of academic impact, for papers by Alireza Ghajar
Rankless by CCL
2026